UK Markets closed

Invacare Corporation (IVC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.8715-0.0185 (-2.08%)
At close: 04:00PM EDT
0.8870 +0.02 (+1.78%)
After hours: 05:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.54
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 35.3700
52-week low 30.8000
50-day moving average 31.0230
200-day moving average 31.6056

Share statistics

Avg vol (3-month) 3393.24k
Avg vol (10-day) 3418.91k
Shares outstanding 535.02M
Implied shares outstanding 6N/A
Float 828.1M
% held by insiders 18.17%
% held by institutions 172.64%
Shares short (14 Jul 2022) 47.55M
Short ratio (14 Jul 2022) 410.99
Short % of float (14 Jul 2022) 422.36%
Short % of shares outstanding (14 Jul 2022) 421.17%
Shares short (prior month 14 Jun 2022) 48.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.01
Trailing annual dividend yield 31.46%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Apr 2020
Ex-dividend date 401 Apr 2020
Last split factor 22:1
Last split date 316 Oct 1995

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin -6.35%
Operating margin (ttm)-0.03%

Management effectiveness

Return on assets (ttm)-0.02%
Return on equity (ttm)-23.61%

Income statement

Revenue (ttm)877.24M
Revenue per share (ttm)25.06
Quarterly revenue growth (yoy)2.40%
Gross profit (ttm)239.11M
Net income avi to common (ttm)-55.72M
Diluted EPS (ttm)-0.8300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)52.34M
Total cash per share (mrq)1.47
Total debt (mrq)389.49M
Total debt/equity (mrq)205.74
Current ratio (mrq)1.50
Book value per share (mrq)9.70

Cash flow statement

Operating cash flow (ttm)-28.25M
Levered free cash flow (ttm)-14.51M